Clinical significance of half‐lives of tumor markers α‐fetoprotein and des‐γ‐carboxy prothrombin after hepatectomy for hepatocellular carcinoma-Reference-Cited by-同舟云学术

Clinical significance of half‐lives of tumor markers α‐fetoprotein and des‐γ‐carboxy prothrombin after hepatectomy for hepatocellular carcinoma

Published:2017-09-08 Issue:3 Volume:48 Page:
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Tsukamoto Masayo¹,Nitta Hidetoshi¹,Imai Katsunori¹,Higashi Takaaki¹,Nakagawa Shigeki¹,Okabe Hirohisa¹,Arima Kota¹,Kaida Takayoshi¹,Taki Katsunobu¹,Hashimoto Daisuke¹,Chikamoto Akira¹,Ishiko Takatoshi¹,Beppu Toru¹,Baba Hideo¹

Affiliation:

1. Department of Gastroenterological Surgery, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.12942

Reference37 articles.

1. Rising Incidence of Hepatocellular Carcinoma in the United States

2. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009

3. Adjuvant Chemolipiodolization Reduces Early Recurrence Derived from Intrahepatic Metastasis of Hepatocellular Carcinoma After Hepatectomy

4. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy

5. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic significance of postoperative serological incomplete conversion of AFP and PIVKA-II after hepatic resection for hepatocellular carcinoma: a multicenter analysis of 1755 patients;The Oncologist;2024-06-22

2. Proteomic Analysis Identifies GSN as a Noninvasive Circulating Serum Biomarker for Predicting Early Recurrence of Hepatocellular Carcinoma;Journal of Proteome Research;2024-02-19

3. Proteomics-driven noninvasive screening of circulating serum protein panels for the early diagnosis of hepatocellular carcinoma;Nature Communications;2023-12-18

4. Protein induced by vitamin K absence or antagonist II: Experience to date and future directions;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

5. Proteomics-driven noninvasive screening of circulating serum protein panels for the early diagnosis of hepatocellular carcinoma;2023-04-25